BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27469216)

  • 21. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
    J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal B-cell lymphocytosis: update on diagnosis, clinical outcome, and counseling.
    Parikh SA; Kay NE; Shanafelt TD
    Clin Adv Hematol Oncol; 2013 Nov; 11(11):720-9. PubMed ID: 24896545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
    Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
    Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.
    Kern W; Bacher U; Haferlach C; Dicker F; Alpermann T; Schnittger S; Haferlach T
    Br J Haematol; 2012 Apr; 157(1):86-96. PubMed ID: 22224978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
    N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL.
    Vardi A; Dagklis A; Scarfò L; Jelinek D; Newton D; Bennett F; Almeida J; Rodriguez-Caballero A; Allgood S; Lanasa M; Cortelezzi A; Orlandi E; Veronese S; Montillo M; Rawstron A; Shanafelt T; Orfao A; Stamatopoulos K; Ghia P
    Blood; 2013 May; 121(22):4521-8. PubMed ID: 23596047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monoclonal B-cell lymphocytosis: from literature to laboratory practice].
    Keutgens A; Foguenne J; Gothot A; Tassin F
    Ann Biol Clin (Paris); 2016; 74(2):168-75. PubMed ID: 27029722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal B-cell lymphocytosis: definitions and natural history.
    Shanafelt T; Hanson CA
    Leuk Lymphoma; 2009 Mar; 50(3):493-7. PubMed ID: 19347733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal B cell lymphocytosis: clinical and population perspectives.
    Caporaso NE; Marti GE; Landgren O; Azzato E; Weinberg JB; Goldin L; Shanafelt T
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S115-9. PubMed ID: 20839332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.
    Furtado FM; Scheucher PS; Santana BA; Scatena NF; Calado RT; Rego EM; Matos DM; Falcão RP
    Braz J Med Biol Res; 2017 Apr; 50(5):e6019. PubMed ID: 28423121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
    Strati P; Shanafelt TD
    Blood; 2015 Jul; 126(4):454-62. PubMed ID: 26065657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.
    Klinger M; Zheng J; Elenitoba-Johnson KS; Perkins SL; Faham M; Bahler DW
    Leukemia; 2016 May; 30(5):1055-61. PubMed ID: 26686246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.
    Kleinstern G; O'Brien DR; Li X; Tian S; Kabat BF; Rabe KG; Norman AD; Yan H; Vachon CM; Boddicker NJ; Call TG; Parikh SA; Bruins L; Bonolo de Campos C; Leis JF; Shanafelt TD; Ding W; Cerhan JR; Kay NE; Slager SL; Braggio E
    Am J Hematol; 2020 Aug; 95(8):906-917. PubMed ID: 32279347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
    Shanafelt TD; Kay NE; Call TG; Zent CS; Jelinek DF; LaPlant B; Morice WG; Hanson CA
    Leuk Res; 2008 Sep; 32(9):1458-61. PubMed ID: 18179821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.